                         SEQUENCE LISTING

<110>  Trustees of Dartmouth College
       Madden, Dean R.
 
<120>  DAB2 INHIBITORS FOR THE PREVENTION AND TREATMENT OF CYSTIC 
       FIBROSIS

<130>  DC0567WO

<150>  US 62/078,499
<151>  2014-11-12

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa can be any naturally occurring amino acid

<400>  1

Asn Pro Xaa Tyr 
1               


<210>  2
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa denotes Asn or His.

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is Pro or absent.

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa denotes Val, Leu, Phe, Glu, Asp, Gln, Asn, or His.

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa denotes Pro or Phe.

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa denotes Phe or Gln.

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa denotes Ser, Thr, Asn or Gln.

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa denotes Asn or Ala.

<400>  2

Gln Asn Gly Phe Asp Asn Pro Xaa Xaa Tyr Xaa Xaa Xaa Glu Xaa Met 
1               5                   10                  15      


Gln Xaa 
        


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Gln Asn Gly Phe Asp Asn Pro Asn Tyr Gln Phe Phe Glu Gln Met Gln 
1               5                   10                  15      


Asn 
    


<210>  4
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Gln Asn Gly Phe Asp Asn Pro Asn Pro Tyr Gln Pro Gln Glu Asn Met 
1               5                   10                  15      


Gln Ala 
        


<210>  5
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Gly Ala Leu Phe Leu Gly Phe Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  7
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Gln 
1               5                   10                  


<210>  8
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210>  9
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu 
            20      


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210>  11
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Gly Ala Leu Phe Leu Ala Phe Leu Ala Ala Ala Leu Ser Leu Met Gly 
1               5                   10                  15      


Leu Trp Ser Gln Pro Lys Lys Lys Arg Lys Val 
            20                  25          


<210>  12
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Gln Asn Gly Tyr Glu Asn Pro Thr Tyr Lys 
1               5                   10  


<210>  14
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Gln Asn Gly Tyr Glu Asn Pro Thr Tyr Lys Phe Phe Glu Gln Met Gln 
1               5                   10                  15      


Asn 
    


<210>  15
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Conjugated to FITC

<400>  15

Ala His Ala Gln Asn Gly Phe Asp Asn Pro Asn Tyr Gln Pro Gln Glu 
1               5                   10                  15      


Asn Met Gln Ala 
            20  


<210>  16
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Conjugated to biotin.

<400>  16

Ala His Ala Ser Gly Ser Gly Gly Phe Asp Asn Pro Asn Tyr Gln Pro 
1               5                   10                  15      


Gln Glu Asn Met Gln Ala 
            20          


